Weed (BUDZ) Debt-to-Equity : 1.48 (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Weed Debt-to-Equity?

Weed's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.16 Mil. Weed's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Weed's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $0.11 Mil. Weed's debt to equity for the quarter that ended in Mar. 2024 was 1.48.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Weed's Debt-to-Equity or its related term are showing as below:

BUDZ' s Debt-to-Equity Range Over the Past 10 Years
Min: -5.58 Med: 0.38 Max: 721
Current: 1.48

During the past 13 years, the highest Debt-to-Equity Ratio of Weed was 721.00. The lowest was -5.58. And the median was 0.38.

BUDZ's Debt-to-Equity is ranked worse than
92.08% of 846 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs BUDZ: 1.48

Weed Debt-to-Equity Historical Data

The historical data trend for Weed's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weed Debt-to-Equity Chart

Weed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.33

0.42

1.07

4.44

0.66

Weed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															721.00	-5.58	0.30	0.66	1.48

Competitive Comparison of Weed's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Weed's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Weed's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Weed's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Weed's Debt-to-Equity falls into.

Weed Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Weed's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.168	+	0)	/	0.255
	=	0.66

Weed's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.158	+	0)	/	0.107
	=	1.48

Weed (OTCPK:BUDZ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Weed Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Weed's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Weed (BUDZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Weed Inc (OTCPK:BUDZ) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4920 North Post Trail, Tucson, AZ, USA, 85750

Website

https://www.weedincusa.com

Weed Inc is working on or planning for several different business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations, and harvest for research, product development, processing, and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the Medical Cannabis and Hemp global market space.

Executives

Nicole M Breen	director, 10 percent owner, officer: Secretary/Treasurer	4920 N. POST TRAIL, TUCSON AZ 85750
Elliot Kwestel	director	5 AUERBACH LANE, LAWRENCE NY 11559
Lawrence G Dykers	director	11924 N CENTAURUS PLACE, ORO VALLEY AZ 85737
Glynn A Burkhardt	director, 10 percent owner, officer: Senior Vice President	3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Roger Mccaslin	director	11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Glenn E. Martin	director, 10 percent owner, officer: President and Chairman of BOD	4920 N. POST TRAIL, TUCSON AZ 85750
Robert A Metz	director, officer: Vice President	3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Robert A Leitzman	director, officer: CFO, CAO and V.P.	3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Glynn A. Burkhardt	director, 10 percent owner, officer: Senior V.P.	11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Donald J Steinberg	director, officer: Former Officer and Director	3223 SUMAC ROAD, FALLBROOK CA 92028